Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Processes for the convergent synthesis of calicheamicin derivatives

a technology of convergent synthesis and calicheamicin, which is applied in the field of process for convergent synthesis of calicheamicin derivatives, can solve the problems of low overall yield, complex synthetic methods for constructing calicheamicin derivatives, and inherently toxic calicheamicin moiety

Inactive Publication Date: 2007-08-23
WYETH LLC
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a process to make calicheamicin derivatives, which are used to treat cancer. The process involves reacting a carboxylic acid with a mercapto compound to produce a bilinker-carboxylic acid, which is then reacted with an N-hydroxysuccinimide to produce the desired calicheamicin derivative. The technical effect of this process is to provide a more efficient and flexible method for making these important cancer treatment drugs.

Problems solved by technology

Previously disclosed synthetic methods for constructing calicheamicin derivatives are complicated by multiple calicheamicin containing synthetic steps having low overall yields.
The calicheamicin moiety is inherently toxic, and when already part of a synthetic target necessitates increased safety precautions which must be observed during manipulation and purification of the products of each of the synthetic steps.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Processes for the convergent synthesis of calicheamicin derivatives
  • Processes for the convergent synthesis of calicheamicin derivatives
  • Processes for the convergent synthesis of calicheamicin derivatives

Examples

Experimental program
Comparison scheme
Effect test

example 1

Butanoic acid, 3-mercapto-3-methyl-,2-[(E)-1-[4-(4-hydroxy-4-oxobutoxy)phenyl]ethylidene]hydrazide

[0076]

[0077]To a stirred mixture of 0.5 g [3.4 mmol] of 3-methyl-3-mercapto-butanoic acid hydrazide in 5.0 ml of methanol is rapidly added 0.91 g [4.1 mmol] of 4-(4-acetylphenoxy)-butanoic acid followed by an additional 10 ml of methanol and 1.5 ml of acetic acid and stirring continued for 24 hours. The reaction mixture is filtered and the solid washed with 100 ml of methanol to give 0.78 g of the title compound as a solid.

example 2

Butanoic acid, 3-mercapto-3-methyl-,2-[(E)-1-[4-(4-hydroxy-4-oxobutoxy)phenyl]ethylidene]hydrazide

[0078]

[0079]A mixture of 3-methyl-3-mercapto-butanoic acid hydrazide (4.0 g, 27 mmol), 4-(4-acetylphenoxy)-butanoic acid (5.0 g, 22.5 mmol) and acetic acid (7.5 mL) in methyl alcohol (75 mL) is heated at about 45° C. for about 7 h. The mixture is allowed to cool to room temperature. The white solid (7.12 g, 90%) is collected on a Buchner funnel and washed with MeOH (2×10 mL). 1H NMR (DMSO-d6): δ (ppm) 12.14 (s, 1H), 10.37 and 10.21 (s, 1H), 7.74-7.70 (m, 2H), 6.97-6.95 (m, 2H), 4.04 (t, 2H), 3.09 and 3.04 (s, 2H), 2.66 (s, 1H), 2.41-2.37 (t, 2H), 2.22 and 2.20 (s, 3H), 1.97-1.93 (m, 2H), 1.8 (s, 3H), 1.47 (s, 3H). MS: 375 (M++Na).

example 3

Butanoic acid, 3-mercapto-3-methyl-,2-[(E)-1-[4-[4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-4-oxobutoxy]phenyl]ethylidene]hydrazide

[0080]

[0081]To a mixture of 0.5 g [1.42 mmol] of butanoic acid, 3-mercapto-3-methyl-,2-[(E)-1-[4-(4-hydroxy-4-oxobutoxy)phenyl]ethylidene]hydrazide (Example 1 or 2) and 0.22 g [1.89 mmol] of N-hydroxysuccinimide is added 10 ml of N,N-dimethylformamide followed by the rapid addition of 0.70 g [3.65 mmol] of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride and the mixture stirred at room temperature for 3 hours. The reaction mixture is concentrated in vacuo to a residue which is partitioned between ethyl acetate and water. The separated organic layer is washed with water, saturated sodium chloride and dried (MgSO4). The organic layer is evaporated in vacuo to give an oily residue which crystallized from ethyl acetate-hexane affording 0.21 g of the title compound as a colorless solid.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
pHaaaaaaaaaa
liquid chromatographyaaaaaaaaaa
Login to View More

Abstract

This invention describes processes for the convergent synthesis of calicheamicin derivatives, and similar analogs using bifunctional and trifunctional linker intermediates.

Description

[0001]This application claims priority from U.S. Provisional Application 60 / 775,370 filed Feb. 21, 2006 entitled “Processes For The Convergent Synthesis of Calicheamicin Derivatives” the content of which is incorporated herein in its entirety to the extent that it is consistent with this invention and application.FIELD OF THE INVENTION[0002]This invention describes processes for the convergent synthesis of calicheamicin derivatives, and similar analogs using bifunctional and trifunctional linker intermediates.BACKGROUND OF THE INVENTION[0003]The potent family of antibacterial and antitumor agents known collectively as the calicheamicins or the LL-E33288 complex, are disclosed in U.S. Pat. No. 4,970,198 (1990). The compounds contain a methyltrisulfide that can be reacted with appropriate thiols to form disulfides while at the same time introducing a functional group such as a hydrazide or similar nucleophile. Examples of this reaction with the calicheamicins are given in U.S. Pat. No...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C07C69/74
CPCC07C319/20C07D207/404C07D309/14C07D405/14C07H15/26C07H15/203C07D207/46C07C323/60A61P35/00C07H15/20
Inventor MORAN, JUSTIN KEITHGU, JIANXIN
Owner WYETH LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products